David Hering Adagio Therapeutics, Inc. (ADGI) insider trading activity

ADGI Quotes by TradingView

David Hering is Chief Executive Officer of Adagio Therapeutics, Inc.. Currently has a direct ownership of 8,000 shares of ADGI, which is worth approximately $26,480. The most recent transaction as insider was on Sep 01, 2022, when has been sold 8,000 shares (Common Stock) at a price of $4.52 per share, resulting in proceeds of $36,160. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8K
0% 3M change
0% 12M change
Total Value Held $26,480

David Hering Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2022
BUY
Open market or private purchase
$36,160 $4.52 p/Share
8,000 Added 50.0%
8,000 Common Stock
DH

David Hering

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on ADGI

Follow Adagio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADGI shares.

Notify only if

Insider Trading

Get notified when an Adagio Therapeutics, Inc. insider buys or sells ADGI shares.

Notify only if

News

Receive news related to Adagio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADGI